Amedisys Inc (AMED) Financials
AMED Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.1 billion | 940.4 million |
2023-09-30 | 2.0 billion | 933.9 million |
2023-06-30 | 2.0 billion | 921.6 million |
2023-03-31 | 1.9 billion | 813.6 million |
AMED Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 58.2 million | 9.4 million |
2023-09-30 | -11.0 million | 7.2 million |
2023-06-30 | 52.9 million | 9.1 million |
2023-03-31 | 24.4 million | 3.3 million |
AMED Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 19.3 million |
2023-09-30 | 25.6 million |
2023-06-30 | -80.5 million |
2023-03-31 | 24.9 million |
AMED Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 145.9 million | - | 89.0 million |
2023-09-30 | 78.1 million | - | 88.0 million |
2023-06-30 | 95.4 million | 369.9 million | 85.4 million |
2023-03-31 | 49.4 million | 373.2 million | 85.3 million |
AMED Shares Outstanding
AMED Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.1 million | - | 199.7 million | 2.7 million |
2023-09-30 | 1.2 million | - | 193.0 million | - |
2023-06-30 | 7.9 million | - | 213.0 million | - |
2023-03-31 | 1.6 million | - | 194.6 million | - |
AMED Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 570.8 million | 140.6 million |
2023-09-30 | 556.2 million | 311.6 million |
2023-06-30 | 553.0 million | 297.5 million |
2023-03-31 | 556.4 million | 315.0 million |
AMED
Price: $92.05
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.30 USD
P/E Ratio: 1183.38
Exchange: NMS
Sector: Healthcare
Industry: Medical Care Facilities
Volume: 187889
Ebitda: 29.5 millionMarket Capitalization: 3.0 billion